SUBSCRIBE
SUBSCRIBE

BioSpace Insights

The BioSpace Insights team performs research and analysis on industry trends for BioSpace and clients, producing industry reports, podcasts, events and articles.

Genetically engineered chimeric antigen receptor immune cell with implanted mrna gene strand - 3d illustration
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
 · 
6 min read
 · 
BioSpace Insights
IN PARTNERSHIP WITH DIA
Breaking Down Barriers: The Nuanced Approach to Women’s Representation in Medical Research
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the underrepresentation of women in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 10, 2025
 · 
1 min read
 · 
Lori Ellis
Washington DC – April 3, 2019: Cherry blossom festival with Washington memorial around the tidal basin
IN PARTNERSHIP WITH DIA
Beyond Neutrality: How Nonprofit Organizations Drive Healthcare Innovation and Collaboration
Health-focused nonprofits like the Drug Information Association (DIA) serve as crucial bridge-builders in the healthcare ecosystem during a time of uncertainty.
April 7, 2025
 · 
7 min read
 · 
BioSpace Insights
Digits abstract background with connected line and dots, wave flow. Digital neural networks. Network and connection background for your presentation.
IN PARTNERSHIP WITH ECLIPSEBIO
Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development
AI offers tremendous potential but there are critical and time-consuming flaws in black box AI predictions.
March 31, 2025
 · 
7 min read
 · 
BioSpace Insights
Photo of attendees at the “Investor and Market Insights” panel at the 2025 Cell & Gene Therapy Summit
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
 · 
5 min read
 · 
BioSpace Insights
IN PARTNERSHIP WITH DIA
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
March 27, 2025
 · 
1 min read
 · 
Lori Ellis
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
 · 
1 min read
 · 
BioSpace Insights
IN PARTNERSHIP WITH SMARTLABS
How Modern Vivarium Services Are Revolutionizing Drug Development
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
March 24, 2025
 · 
7 min read
 · 
BioSpace Insights
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
 · 
1 min read
 · 
Lori Ellis
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss life sciences investment and the potential for disruption.
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Business
Navigating Patient Journeys with Tom Whitehead
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis and Tom Whitehead continue to discuss the patient and caregiver experience, where Tom gives his insights to the future of CGTs.
February 13, 2025
 · 
1 min read
 · 
Lori Ellis
Peera_Sathawirawong/Getty Images
Partnered
The APAC Opportunity: Why Clinical Trials Are Shifting East
APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.
February 3, 2025
 · 
7 min read
 · 
BioSpace Insights
Business
The Patient’s Perspective with Tom Whitehead
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis talks to Tom Whitehead, co-founder of the Emily Whitehead Foundation, about how standard care, cell and gene therapies and their impact on patients.
January 30, 2025
 · 
1 min read
 · 
Lori Ellis
Employer Resources
Report: 2025 Employment Outlook
In this Employment Outlook report, BioSpace explores current workforce sentiment, job activity trends and the prospective job and hiring outlook for 2025, particularly as it compares to the previous year.
January 28, 2025
 · 
1 min read
 · 
BioSpace Insights
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.
January 16, 2025
 · 
1 min read
 · 
Lori Ellis
Load More